Helen joined the Participant Panel in 2018 having been recruited to the 100,000 Genomes Project in 2017 due to endometrial (womb) cancer. A tiny spelling mistake in Helen’s DNA means she has Lynch syndrome, an inherited condition which increases her chance of developing cancer, particularly bowel cancer. Helen is a keen advocate for participants and patients with gynaecological cancers and genetic cancer susceptibilities, which has led her to become a patient representative for the endometrial cancer GECIP domain, CanGene-CanVar and the NCRI Gynaecological Group. She also leads Peaches Womb Cancer Trust Patient Voices group.
